Investors
 

NASDAQ: TTPH

$ 38.00

4.81 (14.49%)

Day High: 39.50
Day Low:  37.45
Volume:    1,608,600

4:00 PM ET
Dec 18, 2014



Delayed at least 20 min., by eSignal.


Stock price graph

     

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Dec 17, 2014
Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections

Dec 15, 2014
Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index